SCHEMBL30124908

SCHEMBL30124908

CC(=O)n1cccc1C(=O)N1CCN(c2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 5/20 0.48
PARP10 Q53GL7 5/20 0.48
PARP1 P09874 1/20 0.46
CASP6 P55212 1/20 0.46
GFER P55789 1/20 0.46
KMT2A Q03164 4/20 0.44
LMNA P02545 2/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA10 Q9GZZ6 1/20 0.43
CHRNA9 Q9UGM1 1/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 2/20 0.43
SLC6A7 Q99884 1/20 0.43
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.42
MAPT P10636 1/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30124750 0.85 CYP1A2 (0.58) PARP14PARP10PARP1KMT2AMEN1
SCHEMBL30124974 0.82 ALDH1A1 (0.48) CASP6GFERKMT2APOLBMEN1
SCHEMBL30124760 0.81 NAMPT (0.47) CASP6GFERKMT2APOLBMEN1
SCHEMBL23928600 0.80 MAPT (0.43) CASP6GFERKMT2ALMNAPOLB
SCHEMBL4985313 0.79 GFER (0.70) PARP14PARP10CASP6GFERKMT2A
SCHEMBL3276407 0.74 MEN1 (0.74) PARP14PARP10KMT2ALMNAPOLB
SCHEMBL7258616 0.74 CASP6 (0.53) PARP14PARP10PARP1CASP6GFER
SCHEMBL23928559 0.73 MAPT (0.43) KMT2ALMNAPOLBMEN1ALDH1A1
SCHEMBL23928587 0.72 NPSR1 (0.60) KMT2ALMNAMEN1ALDH1A1MAPT
SCHEMBL30125096 0.71 NAMPT (0.57) PARP14PARP10PARP1GFERKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548875-B2 Inhibitor compounds for male contraception UNIVERSITY OF WASHINGTON (US) 2023-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11548875-B2 Inhibitor compounds for male contraception ALDH1A1, ALDH3A1, ALDH16A1 PARP14 880/4885PARP10 1073/4885PARP1 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.